L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinoma
Article in Cell Death & Disease (September 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Inhibition of NNMT enhances drug sensitivity in lung cancer cells through mediation of autophagy
Article in Frontiers in Pharmacology (July 2024)
Discovery of 4-((3,4-dichlorophenyl)amino)-2-methylquinolin-6-ol derivatives as EGFR and HDAC dual inhibitors
Article in European Journal of Pharmacology (October 2023)